SPECIFIC BINDING-SITES FOR INSULIN AND INSULIN-LIKE GROWTH FACTOR-I IN HUMAN ENDOMETRIAL CANCER
SPECIFIC BINDING-SITES FOR INSULIN AND INSULIN-LIKE GROWTH FACTOR-I IN HUMAN ENDOMETRIAL CANCER
复制标题
DOI:
10.1016/0002-9378(91)90047-u
复制
发表时间:
1991-12-01
影响因子:
9.8
通讯作者:
DOHERTY, MG
中科院分区:
文献类型:
--
作者:
NAGAMANI, M;STUART, CA;DOHERTY, MG
Insulin and insulin-like growth factor I are known to be mitogenic and therefore may play a role in the development of endometrial cancer. We undertook this study to investigate whether human endometrial cancer tissue has receptors for these substances. Endometrial cancer tissue samples were obtained at hysterectomy from 10 women with endometrial cancer, and control endometrial tissue was collected from normal cycling women undergoing hysterectomy for nonendocrine problems. Binding studies with iodine 125-insulin and [I-125]insulin-like growth factor I revealed the presence of specific binding sites for insulin and insulin-like growth factor I in both normal endometrium and endometrial cancer tissue. The percent binding of [I-125]insulin in the endometrial cancer tissue (mean +/- SE 2.4% +/- 0.5%/100-mu-g protein) was not significantly different from that in normal endometrium (3.5% +/- 1%/100-mu-g protein). On the contrary, the percent total binding of [I-125]insulin-like growth factor I in the endometrial cancer (5.3% +/- 1.5%/100-mu-g protein) was significantly (p < 0.04) higher than that observed in normal endometrium (2.1% +/- 0.4%/100-mu-g protein). There was a significant positive correlation between the histologic grade of the tumor and the insulin-like growth factor I binding (r = 0.865, p < 0.02). The affinity constants for the high-affinity receptors were similar in the normal and neoplastic endometrium. These results indicate that insulin and insulin-like growth factor I may play a role in the growth and development of endometrial cancer.